CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"Fresenius unit dinged in FDA warning letter flagging 'complaint trend' from customers","$":{"href":"/pharma/fresenius-unit-dinged-fda-warning-letter-flagging-complaint-trend-customers","hreflang":"en"}}]}

RegulatoryNegative
AI Analysis

Summary

Fresenius' Utah manufacturing unit received an FDA warning letter following customer complaints, a Form 483, and a product recall earlier in the year. The warning letter highlights a complaint trend from customers regarding the facility's operations.

Outcome Details

FDA warning letter issued to Fresenius manufacturing unit in Utah following customer complaints, Form 483, and recall

Importance:6/10
Sentiment:
-0.80
FDAwarning lettermanufacturingcompliancequality controlrecall
Related Companies

Read the original article

Published by FiercePharma on September 3, 2026 3:01 PM

Read Original